Literature DB >> 9769816

Brain injury and neurometabolic abnormalities in systemic lupus erythematosus.

S D Friedman1, C A Stidley, W M Brooks, B L Hart, W L Sibbitt.   

Abstract

PURPOSE: To investigate with statistical analysis the relationship between brain injury measured with magnetic resonance (MR) imaging and that measured with proton (hydrogen-1) MR spectroscopy.
MATERIALS AND METHODS: Forty-two patients (34 female, eight male; mean age +/- SD, 38.7 years +/- 13.1; age range, 6-60 years) with systemic lupus erythematosus (SLE) were examined with H-1 MR spectroscopy to measure N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) levels in normal-appearing white matter and with MR imaging to detect anatomic abnormalities.
RESULTS: Results of linear regression analysis revealed an association between the NAA/Cr ratio and anatomic abnormalities (P = .03). However, only small focal lesions were independently related to NAA/Cr ratio changes (P = .04). Results of a similar analysis showed associations between the Cho/Cr ratio and anatomic abnormalities (P = .002). An elevated Cho/Cr ratio and cerebral infarction were independently associated (P = .02), as were a decreased Cho/Cr ratio and severe cortical atrophy (P = .02).
CONCLUSION: Cerebrovascular abnormalities underlie diffuse cerebral injury in SLE, with small vessel injury (i.e., small focal lesions) primarily associated with a decreased NAA/Cr ratio and medium vessel injury (i.e., infarct) primarily associated with an increased Cho/Cr ratio. Statistical integration of H-1 MR spectroscopic and MR imaging findings over large data sets provides insights into the relevance of individual MR imaging-visible brain abnormalities in SLE. This statistical approach may be applicable to other systemic diseases complicated by brain injury.

Entities:  

Mesh:

Year:  1998        PMID: 9769816     DOI: 10.1148/radiology.209.1.9769816

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

Review 1.  Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging.

Authors:  Jeffrey R Wozniak; Kelvin O Lim
Journal:  Neurosci Biobehav Rev       Date:  2006-08-07       Impact factor: 8.989

2.  Development and aging of the cerebrum: assessment with proton MR spectroscopy.

Authors:  T Kadota; T Horinouchi; C Kuroda
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

Authors:  J S Axford; F A Howe; C Heron; J R Griffiths
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus.

Authors:  P C Sundgren; J Jennings; J T Attwood; B Nan; S Gebarski; W J McCune; Y Pang; P Maly
Journal:  Neuroradiology       Date:  2005-07-09       Impact factor: 2.804

5.  The effect of corticosteroid medication on quantitative MR parameters of the brain.

Authors:  Stefan C A Steens; Gerda M Steup-Beekman; Gerlof P Th Bosma; Faiza Admiraal-Behloul; Hans Olofsen; Joost Doornbos; Tom W J Huizinga; Mark A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

6.  The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus.

Authors:  William M Brooks; Wilmer L Sibbitt; Mario Kornfeld; Rex E Jung; Arthur D Bankhurst; Carlos A Roldan
Journal:  Arthritis Rheum       Date:  2010-07

7.  Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.

Authors:  G Castellino; M Govoni; M Padovan; P Colamussi; M Borrelli; F Trotta
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

8.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

9.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; William M Brooks; Mario Kornfeld; Blaine L Hart; Arthur D Bankhurst; Carlos A Roldan
Journal:  Semin Arthritis Rheum       Date:  2009-10-31       Impact factor: 5.532

Review 10.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.